Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Lian, Meng ^a   Fang, Jugao ^a   Han, Demin ^a,b   Ma, Hongzhi ^a   Feng, Ling ^a   Wang, Ru ^a   Yang, Fan ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CARCINOGENESIS; CDK1 GENE; CDK2 GENE; CDK4 GENE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC MARKER; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; LARYNX SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MCM2 GENE; MCM3 GENE; MICROARRAY ANALYSIS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERY ELDERLY; BIOSYNTHESIS; CELL TRANSFORMATION; CLINICAL TRIAL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LARYNX TUMOR; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84891310295     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084854     Document Type: Article

References (53)

1. Wu H, Liu T, Wang R, Tian S, Liu M et al. (2011) MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. IUBMB Life 63(2): 101-108. PubMed: 21360639.
2. Fleskens SA, van der Laak JA, Slootweg PJ, Takes RP (2010) Management of Laryngeal Premalignant Lesions in the Netherlands. Laryngoscope 120(7): 1326-1335. doi:10.1002/lary.20888. PubMed: 20564658.
3. Ren J, Zhu D, Liu M, Sun Y, Tian L (2010) Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer 46(18): 3409-3416. doi:10.1016/j.ejca. 2010.07.047. PubMed: 20801640.
4. Hunter KD, Parkinson EK, Harrison PR (2005) Profiling early head and neck cancer. Nat Rev Cancer 5: 127-135. doi:10.1038/nrc1549. PubMed: 15685196. (Pubitemid 40220338)
5. Cosetti M, Yu GP, Schantz SP (2008) Five-year survival rates and time trends of laryngeal cancer in the US population. Arch Otolaryngol Head Neck Surg 134: 370-379. doi:10.1001/archotol.134.4.370. PubMed: 18427002. (Pubitemid 351581084)
6. Geiger TR, Peeper DS (2009) Metastasis mechanisms. Biochim Biophys Acta 1796: 293-308. PubMed: 19683560.
7. Makrilia N, Kollias A, Manolopoulos L, Syrigos K (2009) Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 27: 1023-1037. doi:10.3109/07357900902769749. PubMed: 19909018.
8. Thiele W, Sleeman JP (2006) Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol 124(1): 224-241. doi:10.1016/j.jbiotec.2006.01. 007. PubMed: 16497404. (Pubitemid 43816134)
9. Boonkitticharoen V, Kulapaditharom B, Leopairut J, Kraiphibul P, Larbcharoensub N et al. (2008) Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 134(12): 1305-1311. doi:10.1001/archotol.134.12.1305. PubMed: 19075127.
10. Mallis A, Teymoortash A, Mastronikolis NS, Werner JA, Papadas TA (2012) MMP-2 expression in 102 patients with glottic laryngeal cancer. Eur Arch Otorhinolaryngol 269(2): 639-642. doi:10.1007/s00405-011-1625-8. PubMed: 21667117.
11. Tse GM, Yu KH, Chan AW, King AD, Chen GG et al. (2009) HER2 expression predicts improved survival in patients with cervical nodepositive head and neck squamous cellcarcinoma. Otolaryngol Head Neck Surg 141(4): 467-473. doi:10.1016/j.otohns.2009.06.747. PubMed: 19786214.
12. Li JJ, Zhang GH, Yang XM, Li SS, Liu X et al. (2012) Reduced Ecadherin expression is associated with lymph node metastases in laryngeal squamous cell carcinoma. Auris Nasus Larynx 39(2): 186-192. doi:10.1016/j.anl.2011.04.003. PubMed: 21570223.
13. Liu Y, Li G, Su ZW, Qiu YZ, Zhang X et al. (2013) Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngealsquamous cell carcinoma. Zhonghua Bing Li Xue Za Zhi 42(2): 111-115. PubMed: 23710918.
14. Gao S, Yang X, Li S, Tang Q (2013) The study on clinical significance of the expression of EGFL7 in laryngeal squamous cell carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 27(3):147-150.
15. Yoshida K, Sasaki R, Nishimura H, Okamoto Y, Suzuki Y et al. (2010) Nuclear factor-kappaB expression as a novel marker of radioresistance in early-stage laryngealcancer. Head Neck 32(5): 646-655. PubMed: 19885926.
16. Han L, Jiang B, Wu H, Wang X, Tang X et al. (2012) High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis oflaryngeal squamous cell carcinoma. Med Oncol 29(4): 2466-2472. doi:10.1007/s12032-011- 0152-1. PubMed: 22274915.
17. Yim WC, Min K, Jung D, Lee BM, Kwon Y (2011) Cross experimental analysis of microarray gene expression data from volatile organic compounds treated targets. Mol Cell. Toxicol 7: 233-241.
18. Colombo J, Fachel AA, De Freitas Calmon M, Cury PM, Fukuyama EE et al. (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncol Rep 21(3): 649-663. PubMed: 19212623.
19. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4): 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609. (Pubitemid 34164012)
20. Jiang Y, Zhang R, Lv H, Li J, Wang M et al. (2013) HGPGD: The Human Gene Population Genetic Difference. Database - PLOS ONE 8(5): e64150. doi:10.1371/journal.pone.0064150.
21. Harris MA, Deegan JI, Lomax J, Ashburner M, Tweedie S et al. (2008) The Gene Ontology project in 2008. Nucleic Acids Res 36: 440-444.
22. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30. doi:10.1093/nar/28.7.e27. PubMed: 10592173. (Pubitemid 30047706)
23. Kearsey SE, Labib K (1998) MCM proteins: evolution, properties, and role in DNA replication. Biochim Biophys Acta 1398: 113-136. doi: 10.1016/S0167-4781(98)00033-5. PubMed: 9689912. (Pubitemid 28305206)
24. Han JY, Wang H, Xie YT, Li Y, Zheng LY et al. (2012) Association of Germline Variation in CCNE1 and CDK2 with Breast Cancer Risk, Progression and Survival among Chinese Han Women. PLOS ONE 7(11): e49296. doi:10.1371/journal. pone.0049296. PubMed: 23185313.
25. Dong Z, Liu LH, Han B, Pincheira R, Zhang JT (2004) Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23: 3790-3801. doi:10.1038/sj.onc.1207465. PubMed: 15094776. (Pubitemid 38725692)
26. Liu Z, Dong Z, Yang Z, Chen Q, Pan Y et al. (2007) Role of eIF3a(eIF3 p170) in intestinal cell differentiation and its association with early development. Differentiation 75: 652-661. doi:10.1111/j. 1432-0436.2007.00165.x. PubMed: 17381544. (Pubitemid 47301601)
27. Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T et al. (2008) RPN2 gene confers docetaxel resistance in breast cancer. Nat Med 14(9): 939-948. doi:10.1038/nm.1858. PubMed: 18724378.
28. Gong Z, Xu X, Hou R, Guo Y, Sheng F et al. (2010) Effect of docetaxel on expression of eIF3a in human lung cancer A549 cell line. Zhong NAN da Xue Xue Bao Yi Xue Ban 35(8): 771-776. PubMed: 20818067.
29. Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S et al. (2012) RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. Br J Cancer 107(8): 1233-1238. doi:10.1038/bjc.2012.396. PubMed: 22955852.
30. Prokhorova TA, Blow JJ (2000) Sequential MCM/P1 subcomplex assembly is required to form a heterohexamer with replication licensing activity. J Biol Chem 275: 2491-2498. doi:10.1074/jbc.275.4.2491. PubMed: 10644704. (Pubitemid 30082011)
31. Tachibana KE, Gonzalez MA, Coleman N (2005) Cell-cycledependent regulation of DNA replication and its relevance to cancer pathology. J Pathol 205: 123-129. doi:10.1002/path.1708. PubMed: 15643673. (Pubitemid 40227985)
32. Stoeber K, Tlsty TD, Happerfield L, Thomas GA, Romanov S et al. (2001) DNA replication licensing and human cell proliferation. J Cell Sci 114: 2027-2041. PubMed: 11493639. (Pubitemid 32586628)
33. Vargas PA, Cheng Y, Barrett AW, Craig GT, Speight PM (2008) Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours. J Oral Pathol Med 37(5): 309-318. doi: 10.1111/j.1600-0714.2007.00631.x. PubMed: 18248354. (Pubitemid 351533536)
34. Liu M, Li JS, Tian DP, Huang B, Rosqvist S et al. (2013) MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer. Histol Histopathol 28(4): 481-492. PubMed: 23329420.
35. Mehrotra P, Gonzalez MA, Johnson SJ, Coleman N, Wilson JA et al. (2006) Mcm-2 and Ki-67 Have Limited Potential in Preoperative Diagnosis of Thyroid Malignancy. Laryngoscope 116(8): 1434-1438. doi:10.1097/01.mlg.0000225931.59644. 93. PubMed: 16885749. (Pubitemid 44181460)
36. Kikuchi J, Kinoshita I, Shimizu Y, Kikuchi E, Takeda K et al. (2011) Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in nonsmall cell lung cancer. Lung Cancer 72(2): 229-237. doi:10.1016/j.lungcan.2010.08.020. PubMed: 20884074.
37. Nodin B, Fridberg M, Jonsson L, Bergman J, Uhlén M et al. (2012) High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma. Diagn Pathol 7: 82. doi:10.1186/1746-1596-7-82. PubMed: 22805320.
38. Ha SA, Shin SM, Namkoong H, Lee H, Cho GW et al. (2004) Cancer- Associated Expression of Minichromosome Maintenance 3 Gene in Several Human Cancers and Its Involvement in Tumorigenesis. Clin Cancer Res 10(24): 8386-8395. doi:10.1158/1078-0432.CCR-04-1029. PubMed: 15623617. (Pubitemid 40053401)
39. Gan N, Du Y, Zhang W, Zhou J (2010) Increase of Mcm3 and Mcm4 expression in cervical squamous cell carcinoma. Eur J Gynaecol Oncol 31(3): 291-294. PubMed: 21077471.
40. Chou LC, Yang JS, Huang LJ, Wu HC, Lu CC et al. (2009) The synthesized 2-(2-fluorophenyl)-6, 7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells. J Gastroenterol 44: 1055-1063. doi:10.1007/s00535-009-0111-1. PubMed: 19688288.
41. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166. doi:10.1038/nrc2602. PubMed: 19238148.
42. Han YK, Lee JH, Park GY, Chun SH, Han JY et al. (2013) A possible usage of a CDK4 inhibitor for breast cancer stem cell-targeted therapy. Biochem Biophys Res Commun 430(4): 1329-1333. doi:10.1016/j.bbrc. 2012.10.119. PubMed: 23261434.
43. Shirali S, Aghaei M, Shabani M, Fathi M, Sohrabi M et al. (2013) Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3. Tumour Biol 34(2): 1085-1095. doi:10.1007/s13277-013-0650-1. PubMed: 23345014.
44. Shi T, Mazumdar T, Devecchio J, Duan ZH, Agyeman A et al. (2010) cDNA Microarray Gene Expression Profiling of Hedgehog Signaling Pathway Inhibition in Human Colon Cancer Cells. PLOS ONE 5(10): e13054. doi:10.1371/journal.pone. 0013054. PubMed: 20957031.
45. Lu JW, Lin YM, Chang JG, Yeh KT, Chen RM et al. (2013) Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. Med Oncol 30(1): 379. doi: 10.1007/s12032-012-0379-5. PubMed: 23292829.
46. Lim YC, Cha YY (2011) Epigallocatechin-3-gallate Induces Growth Inhibition and Apoptosis of Human Anaplastic Thyroid Carcinoma Cells Through Suppression of EGFR/ERK Pathway and Cyclin B1/CDK1 Complex. J Surg Oncol 104(7): 776-780. doi:10.1002/jso.21999. PubMed: 21725973.
47. Zhang C, Elkahloun AG, Robertson M, Gills JJ, Tsurutani J et al. (2011) Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance. PLOS ONE 6(8): e23849. doi:10.1371/journal.pone. 0023849. PubMed: 21887332.
48. Mielcarek-Kuchta D, Olofsson J, Golusinski W (2008) Laminin expression in advanced laryngeal squamous cell carcinoma does not correlate to neck metastases. Eur Arch Otorhinolaryngol 265(10): 1257-1261. doi:10.1007/s00405- 008-0666-0. PubMed: 18516614.
49. Dong Z, Liu LH, Han B, Pincheira R, Zhang JT (2004) Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23: 3790-3801. doi:10.1038/sj.onc.1207465. PubMed: 15094776. (Pubitemid 38725692)
50. Dellas A, Torhorst J, Bachmann F, Bänziger R, Schultheiss E et al. (1998) Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83: 1376-1383. doi:10.1002/(SICI)1097-0142(19981001) 83:7. PubMed: 9762939. (Pubitemid 28460089)
51. Chen G, Burger MM (1999) p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. Int J Cancer 84: 95-100. doi:10.1002/(SICI)1097-0215(19990420)84:2. PubMed: 10096238. (Pubitemid 29133817)
52. Yin JY, Shen J, Dong ZZ, Huang Q, Zhong MZ et al. (2011) Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating. DNA Repair - Clinical Cancer Res 17(13): 4600-4609. doi:10.1158/1078-0432.CCR-10-2591.
53. Kurashige J, Watanabe M, Iwatsuki M, Kinoshita K, Saito S et al. (2012) RPN2 expression predicts response to docetaxel in oesophageal squamous cell carcinoma. Br J Cancer 107(8): 1233-1238. doi:10.1038/bjc.2012.396. PubMed: 22955852.